Acalabrutinib N-Oxide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Acalabrutinib N-Oxide

● In Stock

Catalogue No.:VE0011655
CAS No.:N/A
Mol. Formula:C26H23N7O3
Mol. Weight:481.52 g/mol

Additional information on Acalabrutinib N-Oxide

Parent drug

Acalabrutinib

IUPAC Name

(S)-8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazine 7-oxide

Synonyms

N/A

Description

Acalabrutinib N-Oxide is a defined oxidative process-related impurity of the BTK inhibitor acalabrutinib, arising primarily from tertiary amine N-oxidation during synthesis, storage, or exposure to peroxides and other reactive oxygen species. With molecular formula C26H23N7O3 and molecular weight 481.52 g/mol, the species exhibits altered polarity and chromatographic behavior relative to the parent drug, often requiring LC-MS/MS, high-resolution mass spectrometry, and orthogonal HPLC methods for unambiguous characterization and quantification. Although not a nitrosamine, its presence is evaluated within impurity control strategies under ICH Q3A/Q3B and related degradant profiling frameworks.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url